Literature DB >> 25638485

Basal infarct location but not larger infarct size is associated with a successful outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: a cardiovascular magnetic resonance imaging study.

Robbert C Steggerda1, Christiane A Geluk, Wessel Brouwer, Albert C van Rossum, Jurriën M Ten Berg, Maarten P van den Berg.   

Abstract

Alcohol septal ablation (ASA) is successful in most but not in all patients with obstructive hypertrophic cardiomyopathy (HCM). We therefore sought to investigate the relation between infarct location versus infarct size with outcome after ASA in patients with obstructive HCM. Baseline characteristics, procedural characteristics, and cardiovascular magnetic resonance findings at baseline and 4-6 month follow-up after ASA were analysed in 47 patients with obstructive HCM in a single-center retrospective study. Infarct size was determined using late gadolinium enhancement. Infarct location was divided into "basal infarction" and "distal infarction" based on an optimal cut-of value of the distance from the basal septum to the beginning of the infarction. A "successful" outcome was defined as 80% reduction of the invasive gradient with a post-procedural gradient of <10 mmHg. Basal infarctions (n = 31) compared to distal infarctions (n = 16) were associated with successful outcome (100 vs. 38%, P < 0.001). Larger infarct size (n = 20) compared to smaller infarct size (n = 27) was not associated with successful outcome (75 vs. 82%, P = 0.72). A more distal location of the infarction, was the only predictor of a less successful outcome (odds ratio 0.76, 95% confidence interval 0.54-0.98, P = 0.03). Basal versus distal infarctions were also associated with a lower provoked gradient at late (2.6 ± 2.2 years) follow-up (11 (6-20) vs. 27 (12-94) mmHg, P = 0.01). Basal infarctions were associated with a successful outcome after ASA. A larger infarct size was not associated with a better outcome.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25638485     DOI: 10.1007/s10554-015-0606-1

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  20 in total

1.  Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy.

Authors:  Shikhar Agarwal; E Murat Tuzcu; Milind Y Desai; Nicholas Smedira; Harry M Lever; Bruce W Lytle; Samir R Kapadia
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

2.  Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient.

Authors:  C Pollick; H Rakowski; E D Wigle
Journal:  Circulation       Date:  1984-01       Impact factor: 29.690

3.  Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.

Authors:  Willem G van Dockum; Aernout M Beek; Folkert J ten Cate; Jurrien M ten Berg; Olga Bondarenko; Marco J W Götte; Jos W R Twisk; Mark B M Hofman; Cees A Visser; Albert C van Rossum
Journal:  Circulation       Date:  2005-05-02       Impact factor: 29.690

4.  Role of echocardiography and cardiac MRI in depicting morphological and functional imaging findings useful for diagnosing hypertrophic cardiomyopathy.

Authors:  A Guarise; N Faccioli; G Foti; S Da Pozzo; P Meneghetti; G Morana
Journal:  Radiol Med       Date:  2010-10-27       Impact factor: 3.469

5.  Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.

Authors:  Uma S Valeti; Rick A Nishimura; David R Holmes; Philip A Araoz; James F Glockner; Jerome F Breen; Steve R Ommen; Bernard J Gersh; A Jamil Tajik; Charanjit S Rihal; Hartzell V Schaff; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2007-01-04       Impact factor: 24.094

6.  Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.

Authors:  Mahboob Alam; Hisham Dokainish; Nasser M Lakkis
Journal:  Eur Heart J       Date:  2009-02-19       Impact factor: 29.983

7.  Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

Authors:  Paul Sorajja; Steve R Ommen; David R Holmes; Joseph A Dearani; Charanjit S Rihal; Bernard J Gersh; Ryan J Lennon; Rick A Nishimura
Journal:  Circulation       Date:  2012-10-17       Impact factor: 29.690

8.  Usefulness of clinical, echocardiographic, and procedural characteristics to predict outcome after percutaneous transluminal septal myocardial ablation.

Authors:  Chris van der Lee; Bas Scholzel; Jurriën M ten Berg; Marcel L Geleijnse; Herman H Idzerda; Ron T van Domburg; Wim B Vletter; Patrick W Serruys; Folkert J ten Cate
Journal:  Am J Cardiol       Date:  2008-03-10       Impact factor: 2.778

9.  Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.

Authors:  Su Min Chang; Nasser M Lakkis; Jennifer Franklin; William H Spencer; Sherif F Nagueh
Journal:  Circulation       Date:  2004-02-16       Impact factor: 29.690

10.  Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest for the septal coronary anatomy.

Authors:  R C Steggerda; J C Balt; K Damman; M P van den Berg; J M Ten Berg
Journal:  Neth Heart J       Date:  2013-11       Impact factor: 2.380

View more
  1 in total

Review 1.  Cardiovascular imaging 2015 in the International Journal of Cardiovascular Imaging.

Authors:  Hiram G Bezerra; Ricardo A Costa; Johan H C Reiber; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire
Journal:  Int J Cardiovasc Imaging       Date:  2016-05       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.